The p53 gene is a potent determinant of chemosensitivity and radiosensitivity in gastric and colorectal cancers

Journal of Cancer Research and Clinical Oncology

Volumn 122, Issue 6, 1996, Pages 360-365

  Hamada, Madoka ^a   Fujiwara, Toshiyoshi ^a   Hizuta, Akio ^a   Gochi, Akira ^a   Naomoto, Yoshio ^a   Takakura, Norihisa ^b   Takahashi, Kenji ^b   Roth, Jack A ^c   Tanaka, Noriaki ^a   Orita, Kunzo ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b Fukuyama National Hospital   (Japan)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

Apoptosis; Chemoradiosensitivity; Colorectal cancer; Gastric cancer; p53

Indexed keywords

CISPLATIN; DOXORUBICIN; ETOPOSIDE; PROTEIN P53;

ARTICLE; CHEMOSENSITIVITY; COLORECTAL CANCER; CONTROLLED STUDY; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; PRIORITY JOURNAL; RADIOSENSITIVITY; STOMACH CANCER; TUMOR SUPPRESSOR GENE;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; COLONIC NEOPLASMS; COMBINED MODALITY THERAPY; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DNA, NEOPLASM; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; GENES, P53; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MUTATION; RADIATION TOLERANCE; RECTAL NEOPLASMS; STOMACH NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 9344266882     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01220804     Document Type: Article

References (21)

1. Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML, Wyllie AH (1993) Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362:849-852
2. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Paesons R, Trent JM, Lin D, Mercer E, Kinzler KW, Vogelstein B (1993) WAF1, a potent mediator of p53 tumor suppression. Cell 75:817-825
3. El-Diery WS, Harper JW, O'Connor PM, Velculescu VE, Canman CE, Jackman J, Pietenpol JA, Burrell M, Hill DE, Wang Y, Wiman KG, Mercer WE, Kastan MB, Kohn KW, Elledge SJ, Kinzler KW, Vogelstein B (1994) WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res 54:1169-1174
4. Fan S, El-Deiry WS, Bae I, Freeman J, Jondle D, Bhatia K, Fornace AJ, Magrath I, Kohn KW, O'Connor PM (1994) p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents. Cancer Res 54:5824-5830
5. Fujiwara T, Grimm EA, Mukhopadhyay T, Zhang W-W, Owen-Schaub LB, Roth JA (1994) Induction of chemosensitivity in human lung cancer cells in vivo by adenovirus-mediated transfer of the wild-type p53 gene. Cancer Res 54:2287-2291
6. Gavrieli Y, Sherman Y, Ben-Sasson SA (1992) Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119:493-501
7. Harper JE, Adami GR, Wei N, Keyomarsi K, Elledge SJ (1993) The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75:805-81
8. Harris CC, Hollstein M (1993) Clinical implications of the p53 tumor suppressor gene. N Engl J Med 329:1318-1327
9. Hollstein M, Sidransky D, Vogelstein B, Harris CC (1991) p53 mutations in human cancers. Science 253:49-53
10. Horio Y, Takahashi T, Kuroishi T, Hibi K, Suyama M, Niimi T, Shimokata K, Yamakawa K, Nakamura Y, Ueda R, Takahashi T (1993) Prognostic significance of p53 mutations and 3p deletions in primary resected non-small cell lung cancer. Cancer Res 53:1-4
11. Kaufmann SH (1989) Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: a cautionary note. Cancer Res 49:5870-5878
12. Kinzler KW, Vogelstein B (1994) Cancer therapy meets p53. N Engl J Med 331:49-50
13. Lowe SW, Schmitt EM, Smith SW, Osborne BA, Jacks T (1993) p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362:847-849
14. Lowe SW, Ruley HE, Jacks T, Housman DE (1993) p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74:957-967
15. Lowe SW, Bodis S, McClatchey A, Remington L, Ruley HE, Fisher DE, Housman DE, Jacks T (1994) p53 status and the efficacy of cancer therapy in vivo. Science 266:807-810
16. Martin HM, Filiple MI, Morris RW, Lane DP, Silvestre F (1992) p53 expression and prognosis in gastric carcinoma. Int J Cancer 50:859-862
17. Shin DM, Kim J, Ro JY, Hittelman J, Roth JA, Hong WK, Hittelman WN (1994) Activation of p53 gene expression in premalignant lesions during head and neck tumorigenesis. Cancer Res 54:321-326
18. Sinicrope FA, Ruan SB, Cleary KR, Stephens LC, Lee JJ, Levin B (1995) bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis. Cancer Res 55:237-241
19. Thompson AM, Anderson TJ, Condie A, Prosser J, Chetty U, Carter DC, Evans HJ, Steel CM (1992) p53 allele losses, mutations and expression in breast cancer and their relationship to clinicopathological parameters. Int J Cancer 50:528-532
20. Williams GT, Smith CA (1993) Molecular regulation of apoptosis: genetic controls on cell death. Cell 74:777-779
21. Yokozaki H, Kuniyasu K, Kitadai Y, Nishimura K, Todo H, Ayhan A, Yasui W, Ito H, Tahara E (1992) p53 point mutations in primary gastric carcinomas. J Cancer Res Clin Oncol 119:67-70